Data integration into a singular database
Ashfield Pharmacovigilance develops comprehensive strategic plan for client involved in database merger to ensure successful continuation of case processing and reporting while maintaining both databases.
Pharmacovigilance preparation for product launch
Insight Our client, a fast growing company, had recently received recommendation for approval by the FDA Advisory Committee and needed to show the FDA they had the infrastructure... read more
E-submissions through the FDA portal
Insight The FDA was requiring e-submissions be set up through the FDA portal. Ashfield Pharmacovigilance determined that this process would take approximately four hours per client. Seventeen clients... read more
Supporting database integration during a corporate merger
Insight Ashfield’s client, “Client A”, a large pharmaceutical company who continues to grow through acquisition, purchased “Client B”, another large pharmaceutical company. This acquisition required 2,500 cases from... read more
Supporting a wide range of Pharmacovigilance services
Insight In early 2010, Ashfield formed a partnership with a global consumer brands company (consumer care, cosmetics, device, and soap/household cleaning). This relationship continues today. Ashfield provides full... read more
Over a decade of partnership
Insight Ashfield’s partnership with “Client A” began in 2006 with case management for one marketed product and continues today for multiple products both post marketing and in clinical... read more
